Freemark M, Comer M, Korner G
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710.
Endocrinology. 1988 Jun;122(6):2771-9. doi: 10.1210/endo-122-6-2771.
Previous studies from this laboratory provided evidence for the existence of a specific placental lactogen (PL) receptor in tissues of fetal lambs and pregnant sheep. The PL receptor is structurally and functionally distinct from somatotropic (GH) and lactogenic (PRL) receptors, and there are conspicuous differences in the expression of the three receptors during ontogeny. The results of the present study indicate striking differences in the solubilization of PL- and GH-binding sites in maternal and fetal sheep liver. Radiolabeled ovine PL (oPL) bound specifically and with high affinity (Kd, 0.97 nM) to soluble detergent extracts of ovine fetal liver, but there was no specific binding of radiolabeled ovine GH (oGH) or oPRL to soluble extracts or insoluble fractions of fetal liver. When liver microsomes of pregnant sheep were extracted with Triton X-100, 80% of the [125I]oPL-binding sites were recovered in the soluble fraction, but 76% of the [125I]oGH binding sites were recovered in the insoluble pellet. Soluble extracts of maternal liver had high affinity for oPL (Kd, 1.45 nM), but low affinity for oGH (Kd 33 nM) and oPRL (Kd, 1-2 microM). On the other hand, Triton-insoluble fractions of maternal liver had high affinity for oGH (Kd, 0.95 nM) as well as oPL (Kd, 0.91 nM), but low affinity for oPRL (Kd, 1-2 microM). The subunit structure of the [125I]oPL-binding site in soluble fractions of fetal and maternal liver (mol wt, 38-47K) was distinct from that of the [125I]oGH-binding site in Triton-insoluble fractions of maternal liver (mol wt, 54/118K). These findings indicate that treatment of microsomal fractions of fetal and maternal sheep liver with Triton X-100 solubilizes the oPL receptor but not the oGH receptor. The differential solubilization of PL- and GH-binding sites may facilitate purification of the two distinct receptors and clarification of their respective roles in the regulation of fetal and postnatal growth.
该实验室之前的研究为胎羊和妊娠绵羊组织中存在特异性胎盘催乳素(PL)受体提供了证据。PL受体在结构和功能上与生长激素(GH)受体和催乳素(PRL)受体不同,并且这三种受体在个体发育过程中的表达存在显著差异。本研究结果表明,母羊和胎羊肝脏中PL结合位点和GH结合位点的溶解情况存在显著差异。放射性标记的绵羊PL(oPL)以高亲和力(Kd,0.97 nM)特异性结合到绵羊胎肝的可溶性去污剂提取物中,但放射性标记的绵羊GH(oGH)或oPRL与胎肝的可溶性提取物或不溶性部分无特异性结合。当用 Triton X-100 提取妊娠绵羊的肝微粒体时,80%的[125I]oPL结合位点存在于可溶性部分,但76%的[125I]oGH结合位点存在于不溶性沉淀中。母羊肝脏的可溶性提取物对oPL具有高亲和力(Kd,1.45 nM),但对oGH(Kd 33 nM)和oPRL(Kd,1 - 2 μM)具有低亲和力。另一方面,母羊肝脏的Triton不溶性部分对oGH(Kd,0.95 nM)以及oPL(Kd,0.91 nM)具有高亲和力,但对oPRL(Kd,1 - 2 μM)具有低亲和力。胎肝和母羊肝脏可溶性部分中[125I]oPL结合位点的亚基结构(分子量,38 - 47K)与母羊肝脏Triton不溶性部分中[125I]oGH结合位点的亚基结构(分子量,54/118K)不同。这些发现表明,用Triton X-100处理胎羊和母羊肝脏的微粒体部分可溶解oPL受体,但不能溶解oGH受体。PL结合位点和GH结合位点的差异溶解可能有助于纯化这两种不同的受体,并阐明它们在调节胎儿和出生后生长中的各自作用。